Esperion Therapeutics
ESPR
ESPR
189 hedge funds and large institutions have $278M invested in Esperion Therapeutics in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 183 → 189 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.91% less ownership
Funds ownership: 66.02% → 64.11% (-1.9%)
Holders
189
Holding in Top 10
1
Calls
$5.22M
Puts
$4.13M
Top Buyers
| 1 | +$8.55M | |
| 2 | +$7M | |
| 3 | +$3.78M | |
| 4 |
Goldman Sachs
New York
|
+$3.37M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.65M |
Top Sellers
| 1 | -$6M | |
| 2 | -$5.1M | |
| 3 | -$4.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.25M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.1M |